Crossmark

Endoscopic and imaging evaluations of the primary tumor response in patients with proficient mismatch repair colorectal cancer treated with neoadjuvant combination immunotherapy

Crossref DOI link: https://doi.org/10.1007/s10151-024-03088-x

Published Online: 2025-01-16

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Yuegang https://orcid.org/0000-0001-9115-3448
Han, Chengcheng

Cheng, Yao

Hu, Gang

Zhuang, Meng

Wang, Xishan

Tang, Jianqiang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No.82072732)

Beijing Natural Science Foundation (L222054,4232058)
License Information

Text and Data Mining valid from 2025-01-16

Version of Record valid from 2025-01-16
More Information

Article History

Received: 7 September 2024

Accepted: 27 November 2024

First Online: 16 January 2025

Declarations

:

: The authors declare no competing interests.

: The study was approved by the Ethics Committee of Cancer Hospital, Chinese Academy of Medical Sciences (ethical approval number: 23/535–4278).

: All patients provided written informed consent.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below